Searchable abstracts of presentations at key conferences in endocrinology

ea0079009 | Abstracts | BES2021

Lipohypertrophy monitoring study (LIMO): effect of injection site rotation and education on glycemic control

N. Bochanen , K. Decochez , E. Heleu , J. Cuypers , C. Vercammen , P. Coremans , G. Vanhaverbeke , S. Shadid , B. Keymeulen , N. Bolsens , C De Block

Background and Aims: Incorrect injection technique can cause lipohypertrophy resulting in unpredictable insulin release. We aimed to assess the impact of a correct injection technique and lipohypertrophy on HbA1c, hypoglycemia and glucose variability.Methods: 171 insulin-injecting people with diabetes were prospectively evaluated for 6 months. 146 subjects completed the study (75 type 1, 71 type 2). They were provided extensive education concerning injec...

ea0071012 | Chronic complications versus glycaemic variability, time in range and HbA1c in people with type 1 diabetes: sub study of the RESCUE-trial | BES2020

Chronic complications versus glycaemic variability, time in range and HbA1c in people with type 1 diabetes: sub study of the RESCUE-trial

A El Malahi , M Van Elsen , S Charleer , F De Ridder , K Ledeganck , B Keymeulen , L Crenier , R Radermecker , B Lapauw , C Vercammen , F Nobels , C Mathieu , P Gillard , C De Block

Background and aims: So far, HbA1c is the only metric of glucose control showing a strong association with chronic complications. However, it does not reflect short-term glycemic variability nor provides guidance in decreasing risk of hypoglycemia. More widespread use of continuous glucose monitoring (CGM) has changed the way people with type 1 diabetes (T1D) manage their glycemia by providing information about glycemic variability and time spent in different glucose ranges.</...